Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      10x Genomics Reports Third Quarter 2026 Financial Results
      Biotech

      10x Genomics Reports Third Quarter 2026 Financial Results

      November 6, 2026
      Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026
      Biotech

      Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026

      November 5, 2026
      Curis to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026
      Biotech

      Curis to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026

      November 5, 2026
      Orchestra BioMed Announces Pricing of Public Offering
      Biotech

      Orchestra BioMed Announces Pricing of Public Offering

      November 5, 2026
      MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
      Biotech

      MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.

      November 5, 2026
      Co-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and Webcast
      Biotech

      Co-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and Webcast

      November 5, 2026
      INOVIO Announces Pricing of Approximately $75 Million Public Offering
      Biotech

      INOVIO Announces Pricing of Approximately $75 Million Public Offering

      November 5, 2026
      Rakovina Therapeutics to Present Brain-Penetrant ATR Inhibitor Data at the 31st Society for Neuro-Oncology Annual Meeting
      Biotech

      Rakovina Therapeutics to Present Brain-Penetrant ATR Inhibitor Data at the 31st Society for Neuro-Oncology Annual Meeting

      November 5, 2026
      Edgewise Therapeutics Reports Third Quarter 2026 Financial Results
      Biotech

      Edgewise Therapeutics Reports Third Quarter 2026 Financial Results

      November 5, 2026
      Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
      Biotech

      Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

      November 5, 2026
      « 1 … 10 11 12 13 14 … 176 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026